Pharmaceuticals News and Research

RSS

Savient gets bankruptcy court approval to sell all assets to Crealta

Savient Pharmaceuticals, Inc. announced that it has received approval from the U.S. Bankruptcy Court for the District of Delaware to sell substantially all of the assets of Savient, including all KRYSTEXXA assets, to Crealta Pharmaceuticals LLC.

13 Dec 2013

Indegene’s MCM division launches Brand-Focused Solutions for brand marketing teams

Indegene, a leading provider of R&D, commercial, and marketing solutions to top global pharmaceutical and healthcare organizations, today announced that its Multi-channel Marketing (MCM) division has launched a suite of Brand-Focused Solutions for the brand marketing teams.

13 Dec 2013

CEO Cancer Gold Standard accreditation awarded to Boehringer Ingelheim Pharmaceuticals

Boehringer Ingelheim Pharmaceuticals, Inc., the largest U.S. subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior.

13 Dec 2013

VG Life Sciences provides update to HCQ-sorafenib combination Phase I Study for advanced stage solid tumors

VG Life Sciences, a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors.

13 Dec 2013

Novel ISM strategy enables selection of potentially effective cancer therapies for patients

A new individualized systems medicine strategy, developed at the Institute for Molecular Medicine Finland FIMM and the Helsinki University Central Hospital, enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukemia patients have been recently published in the Cancer Discovery journal.

13 Dec 2013

Study: Antisense drugs show activity in wide range of tissues and organs

Antisense therapeutics, a class of drugs comprised of short nucleic acid sequences, can target a dysfunctional gene and silence its activity. A new study has shown that antisense drugs delivered systemically show activity in a wide range of tissues and organs, supporting their broad therapeutic potential in many disease indications, as described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

13 Dec 2013

Brazilian study provides evidence to support effectiveness of Tecta in erosive GERD

Takeda Pharmaceuticals International GmbH announced today results showing pantoprazole magnesium 40 mg (Tecta) was as effective as esomeprazole 40 mg for achieving complete remission (defined as combined endoscopic healing and symptomatic relief) and the mucosal healing rate was high, whilst providing significantly higher symptom relief after 8 weeks.

13 Dec 2013

Health Improvement Institute Founder announces recipients of 2013 Human Research Protection Award

Awards for Excellence in Human Research Protection for 2013 were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.

12 Dec 2013

Retrophin to acquire privately-held company, Kyalin Biosciences

Retrophin, Inc. today announced that it will acquire privately-held Kyalin Biosciences, Inc., an early-stage company based in San Diego, CA, that is developing therapies targeting the core symptoms of autism and related conditions.

12 Dec 2013

Market research report on global and China insulin industry

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 382 million in 2013 at a compound annual growth rate of 7.6%.

12 Dec 2013

New strategy for fighting infection targets patient's cells rather than invading pathogens

As more reports appear of a grim "post-antibiotic era" ushered in by the rise of drug-resistant bacteria, a new strategy for fighting infection is emerging that targets a patient's cells rather than those of the invading pathogens.

12 Dec 2013

Policing practices in Thailand increase PWID's vulnerability to poor health

Recent increasing police activities focused on people who inject drugs in Thailand have involved reported injustices that may lead to riskier behaviors in people who inject drugs (PWID), according to a study published this week in PLOS Medicine.

12 Dec 2013

Researchers discover new mechanism in brain which controls tics in children with TS

A mechanism in the brain which controls tics in children with Tourette Syndrome (TS) has been discovered by scientists at The University of Nottingham.

12 Dec 2013

Heartland Food Products Group makes key breakthrough in sucralose manufacturing technology

Heartland Food Products Group, one of world's leading producers and marketers of zero calorie sweeteners and liquid water enhancers for consumer markets and its sister corporation Lexington Pharmaceuticals announce a breakthrough in sucralose manufacturing technology.

12 Dec 2013

ScinoPharm constructs Changshu plant in China

ScinoPharm today announced that the company has completed construction of its Changshu plant on a 16-acre (6.5-hectare) site.

12 Dec 2013

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions Inc.announced that it has entered into a definitive agreement with Cangene Corporation (TSX: CNJ) under which Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis for an aggregate purchase price of $222 million.

12 Dec 2013

Palo Alto Medical Foundation, El Camino Hospital to explore collaborative partnerships to improve community health

El Camino Hospital and the Palo Alto Medical Foundation today announced that following the return of its delegation to India as part of Mayor Ed Lee's SF Bangalore Sister City Initiative, the organizations will be exploring memoranda of understanding (MOU) with local Indian hospitals, healthcare organizations and technology companies.

12 Dec 2013

Johns Hopkins researchers use lung cancer drug to shrink chordoma in mice

Johns Hopkins researchers say that a drug approved to treat lung cancer substantially shrank tumors in mice that were caused by a rare form of bone cancer called chordoma.

12 Dec 2013

AP, Kaiser Permanente initiate clinical trial to evaluate the efficacy of Promescent lidocaine spray

Absorption Pharmaceuticals LLC in collaboration with Kaiser Permanente announced today the initiation of a clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation. This Phase III, double blind, placebo-controlled, randomized study will measure the intravaginal ejaculatory latency time for subjects aged 18 and older.

11 Dec 2013

First patient enrolled in Otonomy's pivotal Phase 2b study of OTO-104 for Meniere's disease

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b study of OTO-104 for the reduction of vertigo in patients with unilateral Meniere's disease.

11 Dec 2013

Pharmaceuticals News and Research

Savient gets bankruptcy court approval to sell all assets to Crealta

Indegene’s MCM division launches Brand-Focused Solutions for brand marketing teams

CEO Cancer Gold Standard accreditation awarded to Boehringer Ingelheim Pharmaceuticals

VG Life Sciences provides update to HCQ-sorafenib combination Phase I Study for advanced stage solid tumors

Novel ISM strategy enables selection of potentially effective cancer therapies for patients

Study: Antisense drugs show activity in wide range of tissues and organs

Brazilian study provides evidence to support effectiveness of Tecta in erosive GERD

Health Improvement Institute Founder announces recipients of 2013 Human Research Protection Award

Retrophin to acquire privately-held company, Kyalin Biosciences

Market research report on global and China insulin industry

New strategy for fighting infection targets patient's cells rather than invading pathogens

Policing practices in Thailand increase PWID's vulnerability to poor health

Researchers discover new mechanism in brain which controls tics in children with TS

Heartland Food Products Group makes key breakthrough in sucralose manufacturing technology

ScinoPharm constructs Changshu plant in China

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Palo Alto Medical Foundation, El Camino Hospital to explore collaborative partnerships to improve community health

Johns Hopkins researchers use lung cancer drug to shrink chordoma in mice

AP, Kaiser Permanente initiate clinical trial to evaluate the efficacy of Promescent lidocaine spray

First patient enrolled in Otonomy's pivotal Phase 2b study of OTO-104 for Meniere's disease

Event guide: World ADC London eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence